INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
76 hedge funds and large institutions have $30.8M invested in Infinity Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 10 increasing their positions, 26 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
-1
Holders Change %
-1.3%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
10
Reduced
26
Closed
15
Calls
$482K
Puts
$111K
Net Calls
+$371K
Net Calls Change
+$205K
Top Buyers
Top Sellers
1 |
Millennium Management
New York
|
-$1.23M |
2 |
D.E. Shaw & Co
New York
|
-$903K |
3 |
Citadel Advisors
Miami,
Florida
|
-$267K |
4 |
Morgan Stanley
New York
|
-$215K |
5 |
Goldman Sachs
New York
|
-$188K |